| Primary information |
|---|
| CancerPPD ID | 3165 |
| PMID | 17559067 |
| YEAR | 2007 |
| SEQUENCE | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL |
| LENGTH | 40 |
| NAME | Peptide 5 |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | Mix |
| Non-Natural | Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen |
| NATURE | Anticancer |
| ACTIVITY | 10.6 % inhibition of cell proliferation at 1 nM |
| SOURCE | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a |
| Cancer Type | Oral Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Oral mucosa |
| CELL LINE | KB |
| TEST TIME | 24-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | NA |
| SMILES | NA |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|